Facial Injectables Market Size (2024 - 2029)

The facial injectables market is projected to experience significant growth over the forecast period, driven by increasing aesthetic consciousness, the rising number of cosmetic procedures, and the introduction of cost-effective options. The market's expansion is further supported by technological advancements that offer benefits such as reduced recovery times and lower procedural costs. Additionally, the growing geriatric population, a key demographic for cosmetic procedures, is expected to contribute to market growth. Market players are actively enhancing their market share through strategies like product launches and collaborations, which are anticipated to create new opportunities. However, challenges such as product side effects and the absence of supportive reimbursement policies may hinder the market's growth trajectory.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Dermatological Drugs Research Facial Injectables Industry Market Size

Market Size of Facial Injectables Industry

Facial Injectables Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 12.12 Billion
Market Size (2029) USD 16.81 Billion
CAGR (2024 - 2029) 6.77 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Facial Injectables Market Major Players

*Disclaimer: Major Players sorted in no particular order

Facial Injectables Market Analysis

The Facial Injectables Market size is estimated at USD 12.12 billion in 2024, and is expected to reach USD 16.81 billion by 2029, growing at a CAGR of 6.77% during the forecast period (2024-2029).

The outbreak of the pandemic impacted the facial injectables market adversaly. For instance, according to the July 2022 NCBI research article, based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. In addition, a large number of cases of COVID-19 across the globe had a slight negative short-term impact on surgical rates for cosmetic procedures in the initial outbreak phase. However, owing to the resumption of elective services and cosmetic procedures around the world in 2021 and 2022, the market started to gain traction and is expected to continue the upward trend over the forecast period.

The rising aesthetic consciousness and the number of cosmetic procedures, the introduction of cost-effective facial injectables, and the aging population are some of the major factors propelling the market's growth. The cosmetics industry has witnessed a boom over the past decade. In particular, there has been an increase in the total number of non-surgical procedures, such as injections of wrinkle relaxers and dermal fillers, due to the surge in aesthetic appeal and availability of highly advanced aesthetic procedures. This trend is primarily due to the advantages of technology, such as low recovery times, a lower risk of infection, no blood loss, and an overall reduction in procedural costs. For instance, according to the 2021 International Society of Aesthetic Plastic Surgery (ISAPS) report, more than 10,129,528 cosmetic surgical procedures were performed in 2021. The top non-surgical procedures in 2021 include calcium hydroxylapatite (222,785), poly-L-lactic acid (121,087), botulinum toxin, and hyaluronic acid. Therefore, such a high number of facial injectable procedures is anticipated to spur market growth over the forecast period.

In addition, there is a consistent rise in the geriatric population, which helps boost the market's growth. For instance, according to the 2021 WHO report, by 2030, 1 out of every 6 people across the globe will be 60 years of age or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will reach 2.1 billion. Between 2020 and 2050, the number of people aged 80 and above is expected to triple, reaching 426.0 million. Since the geriatric population is the major target group for cosmetic procedures, increasing the geriatric population is likely to boost the market's growth over the forecast period.

The market players are adopting various strategies, such as product launches, developments, collaborations, partnerships, acquisitions, and expansions, to increase their market share. For instance, in September 2021, Aesthetics Innovators launched two new injectables into the aesthetics sphere: MaiLi, a hyaluronic acid (HA) dermal filler that uses less product than traditional fillers, and Lanluma, an industry-first collagen-stimulating filler for the body. As a result, such innovations are expected to create new opportunities for the market, propelling market growth.

However, the side effects of available products and the lack of reimbursement policies supporting cosmetic procedures may impede the market's growth over the forecast period.

Facial Injectables Industry Segmentation

As per the scope of the report, facial injectables aid in rejuvenating the facial skin by reducing wrinkles, raising scar depression, and enhancing the lips. Facial injectables are products that include collagen and hyaluronic acid fillers, as well as synthetic fillers, such as calcium hydroxylapatite. Injectable products, such as hyaluronic acid, increase skin hydration, improve skin, protect from UV damage, and have relatively few side effects. The Facial Injectables Market is Segmented by Type (Wrinkle Relaxers (Botulinum Toxin) and Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, and Other Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Other Application), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The report also covers the estimated market sizes and trends for 17 countries across global regions. The report offers the value (in USD million) for the above segments.

By Type
Wrinkle Relaxers
Botulinum Toxin
Dermal Fillers
Collagen
Hyaluronic Acid
Fat Injection
Polylactic Acid
Polymethyl-methacrylate Microspheres (PMMA)
Calcium Hydroxylapatite
Other Dermal Fillers (Polyalkylimide etc.)
By Application
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Facial Injectables Market Size Summary

The facial injectables market is poised for significant growth over the forecast period, driven by increasing aesthetic consciousness and the rising number of cosmetic procedures. The market, which experienced a temporary setback due to the pandemic, has rebounded with the resumption of elective services and cosmetic procedures. The introduction of cost-effective facial injectables and the aging population are key factors contributing to the market's expansion. The cosmetics industry has seen a surge in non-surgical procedures, such as wrinkle relaxers and dermal fillers, due to technological advancements that offer benefits like reduced recovery times and lower procedural costs. The geriatric population, a major target group for cosmetic procedures, is also on the rise, further boosting market growth. Market players are actively engaging in strategies like product launches and collaborations to enhance their market share, with innovations such as new hyaluronic acid dermal fillers creating new opportunities.

North America is expected to dominate the facial injectables market, supported by higher awareness of aesthetic procedures, technological advancements, and a growing geriatric population. The demand for non-invasive aesthetic procedures is increasing, particularly among older adults, which is driving market growth in the region. The competitive landscape is moderately competitive, with key players like AbbVie Inc. (Allergan Plc), Ipsen SA, and Merz Pharma actively expanding their presence and launching new products. The market's growth is further supported by the increasing use of hyaluronic acid dermal fillers, known for their moisture-binding and skin-enhancing properties. Despite challenges such as product side effects and lack of reimbursement policies, the market is expected to continue its upward trajectory, with North America leading the charge.

Explore More

Facial Injectables Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Aesthetic Consciousness and Number of Cosmetic Procedures

      2. 1.2.2 Introduction of Cost-effective Facial Injectable

      3. 1.2.3 Ageing Population

    3. 1.3 Market Restraints

      1. 1.3.1 Side-effects of Available Products Limiting Adoption

      2. 1.3.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Type

      1. 2.1.1 Wrinkle Relaxers

        1. 2.1.1.1 Botulinum Toxin

      2. 2.1.2 Dermal Fillers

        1. 2.1.2.1 Collagen

        2. 2.1.2.2 Hyaluronic Acid

        3. 2.1.2.3 Fat Injection

        4. 2.1.2.4 Polylactic Acid

        5. 2.1.2.5 Polymethyl-methacrylate Microspheres (PMMA)

        6. 2.1.2.6 Calcium Hydroxylapatite

        7. 2.1.2.7 Other Dermal Fillers (Polyalkylimide etc.)

    2. 2.2 By Application

      1. 2.2.1 Facial Line Correction

      2. 2.2.2 Lip Augmentation

      3. 2.2.3 Face Lift

      4. 2.2.4 Acne Scar Treatment

      5. 2.2.5 Lipoatrophy Treatment

      6. 2.2.6 Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Facial Injectables Market Size FAQs

The Facial Injectables Market size is expected to reach USD 12.12 billion in 2024 and grow at a CAGR of 6.77% to reach USD 16.81 billion by 2029.

In 2024, the Facial Injectables Market size is expected to reach USD 12.12 billion.

Facial Injectables Market Report Snapshots

Facial Injectables Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)